Connect Biopharma Holdings (CNTB) Intangibles (2023 - 2026)

Connect Biopharma Holdings has disclosed Intangibles across 4 years of filings, most recently posting $42000.0 for Q2 2026.

• In Q2 2026, Intangibles fell 12.5% year-over-year to $42000.0; the TTM figure through Jun 2026 stood at $42000.0 (down 12.5% YoY), while the FY2025 annual figure was $45000.0, down 15.09% from the prior year.
• Intangibles came in at $42000.0 for Q2 2026 at Connect Biopharma Holdings, down from $43000.0 in the prior quarter.
• In the past five years, Intangibles ranged from a high of $62000.0 in Q4 2023 to a low of $42000.0 in Q2 2026.
• Average Intangibles over 4 years is $48750.0, with a median of $47500.0 recorded in 2025.
• Year-over-year, Intangibles retreated 15.09% in 2025 and decreased 12.5% in 2026.
• Over 4 years, Intangibles stood at $62000.0 in 2023, then dropped by 14.52% to $53000.0 in 2024, then decreased by 15.09% to $45000.0 in 2025, then retreated by 6.67% to $42000.0 in 2026.
• Per Business Quant data, the three most recent Intangibles figures were $42000.0 in Q2 2026, $43000.0 in Q1 2026, and $45000.0 in Q4 2025.